🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate the non-inferiority of QVA149 110/50 µg o.d. to fluticasone/...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11
Trial ID
NCT01709903
Treatments Being Tested
This study will evaluate the efficacy and safety of QVA149 (110/50 μg o.d.)...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-11-20
Trial ID
NCT02603393
Treatments Being Tested
This study is to assess the safety and tolerability of two different doses ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10
Trial ID
NCT01682863
An investigational inhalation product (QVA149) for the treatment of patient...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00558285
Treatments Being Tested
To demonstrate superiority of QVA149 (110/50 μg) once daily compared to tio...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-03-23
Trial ID
NCT02566031
Treatments Being Tested
This mechanistic study is a single-center, randomized, double-blind, placeb...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-05-18
Trial ID
NCT02442206
Study is to show that QVA149 is superior to the standard of care, fluticaso...
Status
Withdrawn
Location
Novartis Investigative Site
Start Date
2013-12
Trial ID
NCT01834885
Treatments Being Tested
This study will investigate whether switching symptomatic COPD patients fro...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-10-13
Trial ID
NCT02516592
Treatments Being Tested
This study assessed the effect of once-daily indacaterol and glycopyrronium...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-02
Trial ID
NCT01294787
Treatments Being Tested
This study assessed the effect of QVA149 on patient-reported dyspnea in mod...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-10
Trial ID
NCT01490125
Treatments Being Tested